It has been discovered that KRT19 is highly expressed in a number of cancers, including lung adenocarcinoma, ovarian cancer, and breast cancer; and it promotes the growth and metastasis of these cancers and is thought to have some bearing on the prognosis of these cancer [16–19]. This evidence concerns the gene KRT19 and breast carcinoma.